Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.007 AUD | 0.00% | -22.22% | -63.16% |
05-24 | Anagenics Signs Midkine Antibody Licencing Deal with Roquefort Therapeutics | MT |
03-08 | Anagenics Appoints CEO | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-63.16% | 2.14M | |
+12.28% | 388B | |
+12.61% | 136B | |
+16.62% | 76.27B | |
-10.96% | 65.56B | |
-15.65% | 44.23B | |
-10.36% | 36.96B | |
+6.37% | 35.04B | |
+7.80% | 18.02B | |
+12.30% | 15.57B |
- Stock Market
- Equities
- AN1 Stock
- News Anagenics Limited
- Cellmid Limited Reports Sales Results for the Second Quarter of Fiscal Year 2018